Science and Enterprise

Tag: NIH

  • NIH Approves Two Human Embryonic Stem Cell Lines

    BioTime Inc., a biotechnology company in Alameda, California, says that two human embryonic stem (hES) cell lines developed by a subsidiary have been approved by National Institutes of Health (NIH) for the NIH Human Embryonic Stem Cell Registry. Approval by NIH allows the use of these cell lines in federally funded research; only hES cell…

  • NIH Panel to Study Biomedical Workforce Future

    A National Institutes of Health (NIH) working group will study the U.S. biomedical workforce of the future, but with limited input from private companies. Of the 12 members of the panel, only one participant — Garry Neil, vice president of Johnson & Johnson in New Brunswick, New Jersey — is from the private sector. The…

  • SBIR Grant Awarded for Drug-to-Drug Interactions Research

    Optivia Biotechnology Inc. in Menlo Park, California received a $1.85 million Small Business Innovation Research (SBIR) grant from National Institutes of Health to determine the mechanisms that underlie certain drug-to-drug interactions, to help improve medication safety. The award was made by the National Institute of General Medical Sciences at NIH. The phase 2 SBIR grant…

  • Cancer Patients, Family Continue Smoking After Diagnosis

    A study by Wake Forest Baptist Medical Center in Winston-Salem, North Carolina finds many patients and their care givers continue smoking even after being told they have cancer. The results of the research by Kathryn Weaver and colleagues appear in the journal Cancer Epidemiology, Biomarkers & Prevention (paid subscription required). Weaver’s team investigated behaviors of…

  • Agencies Use Robotics to Test Chemicals for Toxicity

    National Institutes of Health (NIH) today unveiled a new robotic screening system that will test 10,000 different chemicals for potential toxicity. The system is a result of a collaboration among several federal agencies known as Tox21. The  system is located at NIH’s Chemical Genomics Center in Rockville, Maryland. Tox21 is a joint effort started in…

  • Small Business Grant Awarded for Tuberculosis Test

    Chembio Diagnostics Inc. in Medford, New York has received a three-year $2.9 million Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH) to continue development of a simple, rapid, inexpensive, and accurate blood serum test for tuberculosis. The grant funds further development of the test, following an earlier SBIR grant to…

  • Canadians, Americans Get Different Drug Info in Web Searches

    A research team at University of British Columbia (UBC) in Vancouver, Canada report that Canadians and Americans get much different search results when they look up prescription drug information online. Their findings were published yesterday in the online issue of the Annals of Pharmacotherapy (paid subscription required). The researchers found residents of the United States…

  • Two Pesticides Linked to Higher Rates of Parkinson’s Disease

    A new study by government and private research institutes shows higher rates of Parkinson’s disease among people using the highly restricted pesticides rotenone and paraquat. The findings were published recently in an online issue of the journal Environmental Health Perspectives. The research team found that people who used either pesticide developed Parkinson’s disease about 2.5…

  • Grant Awarded to Company for Kennedy’s Disease Research

    AndroScience Corp., a drug discovery and development company in San Diego, California, said it received a $3.8 million translational research grant to help develop a treatment for spinal and bulbar muscular atrophy, also called Kennedy’s Disease. The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health awarded the grant. The…

  • Device Maker, Heart Institute Fund Cardiac Device Study

    The National Heart, Lung and Blood Institute (NHLBI) and HeartWare, a developer of left ventricular assist devices in Framingham, Massachusetts, have awarded $13.3 million to two universities explore the potential of heart devices for people with heart failure. NHLBI is part of the U.S. National Institutes of Health. The University of Michigan Cardiovascular Center and…